A PHASE I/II TRIAL OF THE COMBINATION OF ROMIDEPSIN AND LENALIDOMIDE IN PATIENTS WITH RELAPSED/REFRACTORY LYMPHOMA AND MYELOMA: 016

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles